David S. Chernow has been the CEO of Select Medical Holdings since 2010. He brings a wealth of experience from previous roles, including President and CEO of Oncure Medical Corp. and a leadership position at JA Worldwide, the largest nonprofit...

Number of Employees

54.6K

Year

2023

Total Compensation

$9.10M

Salary

$995.00K

Board Justification

The compensation philosophy is designed to reward contributions to the Company’s financial performance and provide overall compensation sufficient to attract and retain highly skilled NEOs, aligning their interests with those of stockholders.

Bonus

$1.89M

Board Justification

Based on the Company's performance metrics including return on equity and earnings per share, resulting in bonuses equaling 190% of target for each NEO participant.

Other

$340.77K

Board Justification

Includes 401(k) matching contributions, personal use of aircraft, dividends paid on unvested shares of restricted stock, and physical examination reimbursements.

Restricted Stock

$5.88M(250K common stock)

Board Justification

Restricted stock granted under the 2020 Equity Plan, which will vest in full in equal installments on each of the first three anniversaries of the date of grant beginning on August 1, 2024, subject to continued employment.

Performance Metrics

The performance metrics for determining the compensation included adjusted earnings per share and return on equity.

SEC Filing

From March 15, 2024

David S. Chernow

CEO of Select Medical Holdings

S

Education

Field of Expertise

Business & Management

Born

Invalid Date - 0 years ago

Is Founder?

No

Current Tenure

14 years 4 months (Sep 2010 - Present)

Previous Experience

President and CEO of Oncure Medical Corp., President and CEO of JA Worldwide